Get the latest news, insights, and market updates on PIII (P3 Health Partners Inc.). Explore the news page 1 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
How Recent Developments Are Reframing The P3 Health Partners (PIII) Investment Story
The recent move to a reduced US$12.50 price target for P3 Health Partners, alongside an unchanged fair value estimate of US$10.25, signals a recalibration of expectations rather than a rewrite of the core story. Bullish analysts see the updated target as a reset on timing after weaker Q3 aEBITDA, while still pointing to underlying operational progress that they believe is not fully showing up in the numbers yet. As you read on, keep an eye on how these differing views shape the evolving... Jan 8, 2026 - $PIII
Why The Narrative Around P3 Health Partners Is Shifting After Recent Q3 Weakness And Outlook Reset
P3 Health Partners has seen its price target revised to $12.50 even as fair value per share holds steady at $10.25 and the discount rate remains fixed at 12.5%. This underscores a more nuanced narrative around risk and long term potential. While analysts wrestle with a Q3 aEBITDA miss and stronger revenue growth expectations of roughly 11.1% vs prior 6.1%, the updated target reflects a recalibration of timing rather than a complete rethink of the growth story. Read on to see how you can stay... Dec 22, 2025 - $PIII
What The Latest Outlook Shift Means For P3 Health Partners Valuation
P3 Health Partners has seen its price target recalibrated, even as the core assumptions behind its fair value of $10.25 per share, the 12.5% discount rate, and roughly 6.1% revenue growth remain effectively intact. This tweak is being framed as a fine tuning of expectations around near term execution risk, not a reversal of confidence in the company’s long term earnings path. Read on to see how investors can stay ahead of these narrative shifts as new data points emerge. Analyst Price Targets... Dec 8, 2025 - $PIII
P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACO
HENDERSON, Nev., December 02, 2025--P3 Health Partners ("P3") (NASDAQ: PIII) and Commonwealth Primary Care ACO (Commonwealth) recently announced the formation of a Joint Venture Management Services Organization (MSO) for its ACO lines of business designed to expand value-based care and enhance support for primary care physicians across Arizona, California, Nevada, Oregon, and North Carolina. Dec 2, 2025 - $PIII
P3 Health Partners to Present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference
Henderson, Nevada--(Newsfile Corp. - November 24, 2025) - P3 Health Partners Inc. (NASDAQ: PIII) ("P3"), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Noble Capital Markets' 21st Annual Emerging Growth Equity Conference. Management is scheduled to present at the conference on Wednesday, December 3, 2025, at 3:30 p.m. Eastern Time. A webcast of the presentation will be available on P3's Investor Relations... Nov 24, 2025 - $PIII
Why The Narrative Around P3 Health Partners Is Shifting After Recent Analyst Revisions
P3 Health Partners stock saw its consensus analyst price target cut from $14.00 to $10.25 per share, a notable drop that highlights revised expectations for the company’s near-term performance. This adjustment reflects increased perceived risk among analysts, with the discount rate rising to 12.5 percent and upgraded forecasts for revenue growth. As the narrative surrounding P3 Health Partners continues to evolve, stay tuned to discover how you can track these shifts and remain informed about... Nov 23, 2025 - $PIII
P3 Health Partners Announces Third Quarter 2025 Results
HENDERSON, Nev., November 13, 2025--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2025. Nov 13, 2025 - $PIII
P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call
HENDERSON, Nev., October 21, 2025--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third quarter 2025 and file its Quarterly Report on Form 10-Q on Friday, November 14, 2025. In connection with the release, management will host a conference call to discuss the financial results at 5:00am PT/ 8:00am ET the same day. Oct 21, 2025 - $PIII
P3 Health Partners to Participate in the Jefferies Healthcare Services Conference
HENDERSON, Nev., September 17, 2025--P3 Health Partners Inc. ("P3") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming Jefferies Healthcare Services Conference. Sep 17, 2025 - $PIII
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple